| Dr Alfred Estin Avery, MD | |
|
2807 1st Ave N, Billings, MT 59101-2311 | |
| (406) 896-0483 | |
| (406) 259-9479 |
| Full Name | Dr Alfred Estin Avery |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Pain Medicine |
| Location | 2807 1st Ave N, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063587426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P2900X | Psychiatry & Neurology - Pain Medicine | 10258 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alfred Estin Avery, MD 2807 1st Ave N, Billings, MT 59101-2311 Ph: (406) 896-0483 | Dr Alfred Estin Avery, MD 2807 1st Ave N, Billings, MT 59101-2311 Ph: (406) 896-0483 |
News Archive
Controlled application of vacuum pressure is a promising approach to limiting tissue damage after traumatic brain injury (TBI), suggests an experimental study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Mass., manufacturing facility and will turn over to the federal government $175 million in unlawful profits from the sale of products that were made at the plant, the U.S. Food and Drug Administration announced today.
Researchers in the United States say one of the reasons why many patients do not do well after blood transfusions is because donated blood rapidly loses some of its life-saving properties.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
King Pharmaceuticals, Inc. announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.
› Verified 6 days ago
James Frederick Richards, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-3850 Fax: 406-237-3855 | |
Tiffany White, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Martha Lorena Cruz, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dale M. Peterson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Christopher Evan Stewart, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
John G. Denegre, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1020 N 27th St, Billings, MT 59101 Phone: 406-238-2500 |